A citation-based method for searching scientific literature




Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
Times Cited: 830




List of shared articles



Times cited


GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue.
Jonathan E Campbell, Jacqueline L Beaudry, Berit Svendsen, Laurie L Baggio, Andrew N Gordon, John R Ussher, Chi Kin Wong, Fiona M Gribble, David A D'Alessio, Frank Reimann,[...]. Diabetes 2022
4





Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?
Elizabeth A Killion, Shu-Chen Lu, Madeline Fort, Yuichiro Yamada, Murielle M Véniant, David J Lloyd. Endocr Rev 2020
28

Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease.
Sebastian M Heimbürger, Natasha C Bergmann, Robert Augustin, Lærke S Gasbjerg, Mikkel B Christensen, Filip K Knop. Peptides 2020
11

Cardiovascular biology of the GIP receptor.
Amanda A Greenwell, Jadin J Chahade, John R Ussher. Peptides 2020
5

Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor.
Xiaoshan Min, Junming Yie, Jinghong Wang, Ben C Chung, Ching-Shin Huang, Haoda Xu, Jie Yang, Liying Deng, Joanne Lin, Qing Chen,[...]. MAbs 2020
5

GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review.
Yusaku Mori, Takanori Matsui, Tsutomu Hirano, Sho-Ichi Yamagishi. Int J Mol Sci 2020
14

Glucose signaling in the brain and periphery to memory.
Md Shamim Hossain, Yutaka Oomura, Takehiko Fujino, Koichi Akashi. Neurosci Biobehav Rev 2020
7


Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.
Yukiko Fu, Kentaro Kaneko, Hsiao-Yun Lin, Qianxing Mo, Yong Xu, Takayoshi Suganami, Peter Ravn, Makoto Fukuda. Endocrinology 2020
13

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Therese S Salameh, Elizabeth M Rhea, Konrad Talbot, William A Banks. Biochem Pharmacol 2020
25

GIP(3-30)NH2 - a tool for the study of GIP physiology.
Mads Bank Lynggaard, Lærke Smidt Gasbjerg, Mikkel Bring Christensen, Filip Krag Knop. Curr Opin Pharmacol 2020
2

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.
Alice E Adriaenssens, Emma K Biggs, Tamana Darwish, John Tadross, Tanmay Sukthankar, Milind Girish, Joseph Polex-Wolf, Brain Y Lam, Ilona Zvetkova, Warren Pan,[...]. Cell Metab 2019
86

Gut hormone polyagonists for the treatment of type 2 diabetes.
Sara J Brandt, Anna Götz, Matthias H Tschöp, Timo D Müller. Peptides 2018
67

Effects of GIP on regional blood flow during normoglycemia and hyperglycemia in anesthetized rats.
Xiang Gao, Andreas Lindqvist, Monica Sandberg, Leif Groop, Nils Wierup, Leif Jansson. Physiol Rep 2018
1

Glucose-Dependent Insulinotropic Polypeptide Suppresses Peripheral Arterial Remodeling in Male Mice.
Yusaku Mori, Hideki Kushima, Masakazu Koshibu, Tomomi Saito, Munenori Hiromura, Kyoko Kohashi, Michishige Terasaki, Yutaka Seino, Yuichiro Yamada, Tsutomu Hirano. Endocrinology 2018
14

Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Mahip K Verma, Rajan Goel, Nandakumar Krishnadas, Kumar V S Nemmani. Expert Opin Ther Targets 2018
14

Effect of D-Ala2GIP, a stable GIP receptor agonist on MPTP-induced neuronal impairments in mice.
Mahip K Verma, Rajan Goel, Krishnadas Nandakumar, Kumar V S Nemmani. Eur J Pharmacol 2017
14


N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor.
L S Hansen, A H Sparre-Ulrich, M Christensen, F K Knop, B Hartmann, J J Holst, M M Rosenkilde. Br J Pharmacol 2016
56